[go: up one dir, main page]

WO2008147169A8 - Microémulsion contenant de la pirfénidone - Google Patents

Microémulsion contenant de la pirfénidone Download PDF

Info

Publication number
WO2008147169A8
WO2008147169A8 PCT/MX2008/000068 MX2008000068W WO2008147169A8 WO 2008147169 A8 WO2008147169 A8 WO 2008147169A8 MX 2008000068 W MX2008000068 W MX 2008000068W WO 2008147169 A8 WO2008147169 A8 WO 2008147169A8
Authority
WO
WIPO (PCT)
Prior art keywords
microemulsion containing
containing pirfenidone
pirfenidone
microemulsion
capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MX2008/000068
Other languages
English (en)
Spanish (es)
Other versions
WO2008147169A3 (fr
WO2008147169A2 (fr
Inventor
José Agustín Rogelio MAGAÑA CASTRO
Juan Socorro Armendariz Borunda
Laura VÁZQUEZ CERVANTES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Therapy and Technology SA de CV
Original Assignee
Cell Therapy and Technology SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapy and Technology SA de CV filed Critical Cell Therapy and Technology SA de CV
Publication of WO2008147169A2 publication Critical patent/WO2008147169A2/fr
Publication of WO2008147169A3 publication Critical patent/WO2008147169A3/fr
Publication of WO2008147169A8 publication Critical patent/WO2008147169A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition microémulsionnable de Pirfénidone, qui présente des avantages par rapport à d'autres formes pharmaceutiques à administrer par voie orale connues dans l'état de la technique, comme des comprimés, capsules, suspensions et solutions.
PCT/MX2008/000068 2007-05-29 2008-05-29 Microémulsion contenant de la pirfénidone Ceased WO2008147169A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXMX/A/2007/006348 2007-05-29
MX2007006438 2007-05-29

Publications (3)

Publication Number Publication Date
WO2008147169A2 WO2008147169A2 (fr) 2008-12-04
WO2008147169A3 WO2008147169A3 (fr) 2009-01-22
WO2008147169A8 true WO2008147169A8 (fr) 2009-07-30

Family

ID=40075678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2008/000068 Ceased WO2008147169A2 (fr) 2007-05-29 2008-05-29 Microémulsion contenant de la pirfénidone

Country Status (1)

Country Link
WO (1) WO2008147169A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
CN102846555B (zh) * 2012-04-09 2014-06-25 珠海亿邦制药股份有限公司 一种以吡非尼酮为活性成分的固体制剂及其应用
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN110452216B (zh) 2014-04-02 2022-08-26 英特穆恩公司 抗纤维化吡啶酮类

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113798B1 (fr) * 1998-09-18 2003-01-02 Mepha AG Formulation topique a base d'alkyl-, phenyl-pyridone
CH696420A5 (de) * 2002-09-13 2007-06-15 Mepha Ag Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung.
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients

Also Published As

Publication number Publication date
WO2008147169A3 (fr) 2009-01-22
WO2008147169A2 (fr) 2008-12-04

Similar Documents

Publication Publication Date Title
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
WO2008037716A3 (fr) Compositions pharmaceutiques
WO2010066749A3 (fr) Comprimés d'ulipristal acétate
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
IL184126A0 (en) Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
NO20085302L (no) Farmasoytisk preparat omfattende Amlodipin og Losartan
JP2009537554A5 (fr)
WO2003026610A3 (fr) Procede de preparation d'une forme posologique a dissolution rapide
WO2008006534A3 (fr) Comprimés à multiples unités
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2008093838A1 (fr) Dérivé de pyridyl imidazolidine ayant un groupe sulfamoyle, et utilisation pharmaceutique de ce dérivé
WO2010012459A3 (fr) Procédé de préparation de sels de solifénacine et inclusion de ces derniers dans des formes pharmaceutiques
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2008147169A3 (fr) Microémulsion contenant de la pirfénidone
WO2007072061A3 (fr) Formulation
WO2009013594A3 (fr) Procédé de préparation de compositions solides à libération contrôlée contenant de l'oxcarbazépine, et compositions obtenues par ce procédé
WO2008059298A3 (fr) Composition pharmaceutique contenant de l'hydrogénosulfate de clopidogrel de forme polymorphe 1
WO2006122777A3 (fr) Utilisation de derives de thiazol-4-one 2,5-disubstitues dans des medicaments
WO2007007182A3 (fr) Formes galeniques solides d'agent antiepileptique
WO2009110010A3 (fr) Forme posologique orale stable
WO2009049961A3 (fr) Nouveaux dérivés d'aspirine donneurs no
WO2007144699A3 (fr) Procédé pour la préparation d'alfuzosine
WO2006012779A8 (fr) Extraits de wikstroemia indeca, production de ceux-ci et utilisation de ceux-ci dans la production de produits pharmaceutiques anti-inflammatoires
WO2009056617A3 (fr) Pipéridines 4,4-disubstituées
PL1819320T3 (pl) Kompozycja farmaceutyczna ulegająca dyspergowaniu w ustach i sposób jej przygotowania

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2